Lori Ann Post

Lori Ann Post

Auto-generated profile, based on publicly available information

Lori Ann Post

Feinberg School of Medicine, Northwestern University, Evanston, IL, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2025 in JAMA Network Open
Verified
Journal Article
Open access
LPLori Ann Post
Lori Ann Post
DCDaniel Ciccarone
Daniel Ciccarone
GUGeorge Jay Unick
George Jay Unick
GDGail D’oNofrio
Gail D’oNofrio
SKSoyang Kwon
Soyang Kwon
MMMaryann Mason
Maryann Mason
Importance: Drug overdose deaths (DODs) surged with the advent of fentanyl. Recent US reports indicated a decline, but standard surveillance systems do not account for monthly variability or seasonality and require monthly population data to calculate DOD rates.Objective: To identify when US DOD rates began to decelerate and to examine patterns by census region, drug type, and demographics.Design, Setting, and Participants: This repeated cross-sectional study of DOD rates was conducted from January 2015 to October 2024, using data from the National Center for Health Statistics and US Census Bureau. Decedents included those whose drug poisoning death was classified as unintentional, intentional (suicide or homicide), or undetermined intent, identified by International Statistical Classification of Diseases and Related Health Problems, 10th Revision codes for external overdose causes and T codes for opioids, cocaine, and psychostimulants (eg, methamphetamine).Main Outcomes and Measures: The main outcome was change in monthly DOD rates nationally and by drug type (opioids, cocaine, or methamphetamine), census region, and demographics. Joinpoint regression evaluated significant shifts in DOD rates applying the weighted bayesian information criterion and 2-sided z tests (α = .05).Results: A total of 800 645 US residents (68.3% male; median age, 42 years [IQR, 33-54 years]) died of drug overdose between January 2015 and October 2024. The national DOD rate increased from 14.54 (95% CI, 14.52-14.55) per 100 000 population in January 2015 to 33.24 (95% CI, 33.15 to 33.33) per 100 000 population in August 2023. From August 2023 to February 2024, the monthly DOD rate declined by −0.36 (95% CI, −0.46 to −0.27) per 100 000 population, accelerating to −0.84 (95% CI, −0.77 to −0.92) per 100 000 population through October 2024 and reaching 24.29 (95% CI, 24.21-24.37) per 100 000 population. Opioid-related DOD rates declined faster than stimulant-related DOD rates (−0.80 [95% CI, −0.74 to −0.87] vs −0.25 [95% CI, −0.23 to −0.27] per 100 000 population). While the national DOD rate peaked in August 2023, rates peaked in the Northeast, Midwest, and South census regions in October 2022 and the West peaked a year later. By late 2023, death rates continued to accelerate among adults aged 55 years or older (0.07 per 100 000 population) and American Indian or Alaska Native (0.02 per 100 000 population), Black or African American (1.70 per 100 000 population), Hispanic or Latino (0.20 per 100 000 population), and multiracial (0.28 per 100 000 population) populations, though the pace of increase was slowing, suggesting a potential inflection point.Conclusions and Relevance: In this cross-sectional study, US DOD rates entered a new wave of sustained deceleration in 2023 after 2 decades of increase. This shift may reflect changes in drug markets, treatment access, harm reduction efforts, and population-level risk. Although the decline is encouraging, persistent disparities highlight the need for targeted interventions and improved understanding of the underlying drivers.

3 September 2013 in Journal of Medical Internet Research
Verified
Journal Article
Open access
LPLori Ann Post
Lori Ann Post
FVFederico E Vaca
Federico E Vaca
KDKelly M. Doran
Kelly M. Doran
CLCali Luco
Cali Luco
MNMatthew Naftilan
Matthew Naftilan
GDGail D'Onofrio
Gail D'Onofrio
New Media Use by Patients Who Are Homeless: The Potential of mHealth to Build Connectivity

19 May 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
EMEdward R Melnick
Edward R Melnick
EHErik P Hess
Erik P Hess
GGGeorge Guo
George Guo
MBMaggie Breslin
Maggie Breslin
KLKevin Lopez
Kevin Lopez
LPLori A Post
Lori A Post
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

31 January 2022 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
ALAlexander L Lundberg
Alexander L Lundberg
RLRamón Lorenzo-Redondo
Ramón Lorenzo-Redondo
EOEgon Anderson Ozer
Egon Anderson Ozer
CHClaudia A. Hawkins
Claudia A. Hawkins
JHJudd F. Hultquist
Judd F. Hultquist
LPLori Ann Post
Lori Ann Post
Background: Variants of the SARS-CoV-2 virus carry differential risks to public health. The Omicron (B.1.1.529) variant, first identified in Botswana on November 11, 2021, has spread globally faster than any previous variant of concern. Understanding the transmissibility of Omicron is vital in the development of public health policy. Objective: The aim of this study is to compare SARS-CoV-2 outbreaks driven by Omicron to those driven by prior variants of concern in terms of both the speed and magnitude of an outbreak. Methods: We analyzed trends in outbreaks by variant of concern with validated surveillance metrics in several southern African countries. The region offers an ideal setting for a natural experiment given that most outbreaks thus far have been driven primarily by a single variant at a time. With a daily longitudinal data set of new infections, total vaccinations, and cumulative infections in countries in sub-Saharan Africa, we estimated how the emergence of Omicron has altered the trajectory of SARS-CoV-2 outbreaks. We used the Arellano-Bond method to estimate regression coefficients from a dynamic panel model, in which new infections are a function of infections yesterday and last week. We controlled for vaccinations and prior infections in the population. To test whether Omicron has changed the average trajectory of a SARS-CoV-2 outbreak, we included an interaction between an indicator variable for the emergence of Omicron and lagged infections. Results: The observed Omicron outbreaks in this study reach the outbreak threshold within 5-10 days after first detection, whereas other variants of concern have taken at least 14 days and up to as many as 35 days. The Omicron outbreaks also reach peak rates of new cases that are roughly 1.5-2 times those of prior variants of concern. Dynamic panel regression estimates confirm Omicron has created a statistically significant shift in viral spread. Conclusions: The transmissibility of Omicron is markedly higher than prior variants of concern. At the population level, the Omicron outbreaks occurred more quickly and with larger magnitude, despite substantial increases in vaccinations and prior infections, which should have otherwise reduced susceptibility to new infections. Unless public health policies are substantially altered, Omicron outbreaks in other countries are likely to occur with little warning.

19 November 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
LPLori Ann Post
Lori Ann Post
SASalem T Argaw
Salem T Argaw
CJCameron Jones
Cameron Jones
CMCharles Moss
Charles Moss
DRDanielle Resnick
Danielle Resnick
JOJames Oehmke
James Oehmke
Background: Since the novel coronavirus emerged in late 2019, the scientific and public health community around the world have sought to better understand, surveil, treat, and prevent the disease, COVID-19. In sub-Saharan Africa (SSA), many countries responded aggressively and decisively with lockdown measures and border closures. Such actions may have helped prevent large outbreaks throughout much of the region, though there is substantial variation in caseloads and mortality between nations. Additionally, the health system infrastructure remains a concern throughout much of SSA, and the lockdown measures threaten to increase poverty and food insecurity for the subcontinent’s poorest residents. The lack of sufficient testing, asymptomatic infections, and poor reporting practices in many countries limit our understanding of the virus’s impact, creating a need for better and more accurate surveillance metrics that account for underreporting and data contamination.Objective: The goal of this study is to improve infectious disease surveillance by complementing standardized metrics with new and decomposable surveillance metrics of COVID-19 that overcome data limitations and contamination inherent in public health surveillance systems. In addition to prevalence of observed daily and cumulative testing, testing positivity rates, morbidity, and mortality, we derived COVID-19 transmission in terms of speed, acceleration or deceleration, change in acceleration or deceleration (jerk), and 7-day transmission rate persistence, which explains where and how rapidly COVID-19 is transmitting and quantifies shifts in the rate of acceleration or deceleration to inform policies to mitigate and prevent COVID-19 and food insecurity in SSA.Methods: We extracted 60 days of COVID-19 data from public health registries and employed an empirical difference equation to measure daily case numbers in 47 sub-Saharan countries as a function of the prior number of cases, the level of testing, and weekly shift variables based on a dynamic panel model that was estimated using the generalized method of moments approach by implementing the Arellano-Bond estimator in R.Results: Kenya, Ghana, Nigeria, Ethiopia, and South Africa have the most observed cases of COVID-19, and the Seychelles, Eritrea, Mauritius, Comoros, and Burundi have the fewest. In contrast, the speed, acceleration, jerk, and 7-day persistence indicate rates of COVID-19 transmissions differ from observed cases. In September 2020, Cape Verde, Namibia, Eswatini, and South Africa had the highest speed of COVID-19 transmissions at 13.1, 7.1, 3.6, and 3 infections per 100,0000, respectively; Zimbabwe had an acceleration rate of transmission, while Zambia had the largest rate of deceleration this week compared to last week, referred to as a jerk. Finally, the 7-day persistence rate indicates the number of cases on September 15, 2020, which are a function of new infections from September 8, 2020, decreased in South Africa from 216.7 to 173.2 and Ethiopia from 136.7 to 106.3 per 100,000. The statistical approach was validated based on the regression results; they determined recent changes in the pattern of infection, and during the weeks of September 1-8 and September 9-15, there were substantial country differences in the evolution of the SSA pandemic. This change represents a decrease in the transmission model R value for that week and is consistent with a de-escalation in the pandemic for the sub-Saharan African continent in general.Conclusions: Standard surveillance metrics such as daily observed new COVID-19 cases or deaths are necessary but insufficient to mitigate and prevent COVID-19 transmission. Public health leaders also need to know where COVID-19 transmission rates are accelerating or decelerating, whether those rates increase or decrease over short time frames because the pandemic can quickly escalate, and how many cases today are a function of new infections 7 days ago. Even though SSA is home to some of the poorest countries in the world, development and population size are not necessarily predictive of COVID-19 transmission, meaning higher income countries like the United States can learn from African countries on how best to implement mitigation and prevention efforts.International Registered Report Identifier (IRRID): RR2-10.2196/21955

28 July 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
LPLori Ann Post
Lori Ann Post
ALAlexander Lundberg
Alexander Lundberg
CMCharles B. Moss
Charles B. Moss
CBCynthia A. Brandt
Cynthia A. Brandt
IQIrene Quan
Irene Quan
MMMaryann Mason
Maryann Mason
The US opioid crisis has evolved over time. Ciccarone1 posited a theory of 3 overlapping waves of opioid-involved overdose deaths (OODs) based on supply (iatrogenic and new illicit sources) and demand (social, cultural, and technological). Wave 1, in approximately 2000, was prompted by doctors overprescribing opioid painkillers, which was associated with mass addiction.1 Wave 2 involved heroin; OODs from heroin escalated in 2007 and surpassed those from prescription opioids by 2015.1 Wave 3 involved illicit synthetic opioids, such as fentanyl, the use of which escalated after 2013.1 Further evidence suggests a fourth wave, complicated by the addition of stimulants and the COVID-19 pandemic.2 To inform prevention and mitigation strategies, this cross-sectional study examined trends in OOD rates in urban and rural US counties during the 4 waves.